Editas Medicine, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 7.31 M | $9.28 M | -8.93% | 8.86% |
VANGUARD GROUP INC | 02/11/2025 | 6.82 M | $8.67 M | 2.15% | 8.27% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.75 M | $3.49 M | -18.02% | 3.33% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 2.16 M | $2.74 M | -4.75% | 2.62% |
STATE STREET CORP | 02/14/2025 | 1.87 M | $2.38 M | -23.96% | 2.27% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.81 M | $2.30 M | -4.19% | 2.19% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.79 M | $2.27 M | 53.03% | 2.17% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 1.66 M | $2.10 M | 46.77% | 2.01% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 1.65 M | $2.09 M | 21.38% | 2.00% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.45 M | $1.84 M | 100.00% | 1.76% |
BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 1.30 M | $1.65 M | 647.32% | 1.58% |
UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 1.17 M | $1.49 M | 30.36% | 1.42% |
UBS GROUP AG | 02/14/2025 | 1.12 M | $1.42 M | 171.57% | 1.35% |
JANE STREET GROUP, LLC | 02/14/2025 | 1.07 M | $1.36 M | 24.27% | 1.30% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.07 M | $1.36 M | 184.47% | 1.30% |
MONACO ASSET MANAGEMENT SAM | 02/10/2025 | 1.07 M | $1.36 M | 100.00% | 1.30% |
WOODLINE PARTNERS LP | 02/14/2025 | 838,419 | $1.06 M | -6.89% | 1.02% |
JPMORGAN CHASE & CO | 02/12/2025 | 787,599 | $1.00 M | 2.13% | 0.95% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 608,249 | $772,476 | -1.46% | 0.74% |
KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 528,836 | $671,622 | -2.09% | 0.64% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 440,622 | $559,590 | 31.83% | 0.53% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 400,000 | $508,000 | 100.00% | 0.48% |
STIFEL FINANCIAL CORP | 02/13/2025 | 337,158 | $428,198 | -46.04% | 0.41% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 316,614 | $402,100 | 23.66% | 0.38% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 272,430 | $345,986 | 100.00% | 0.33% |
HENNION & WALSH ASSET MANAGEMENT, INC. | 01/15/2025 | 267,758 | $340,053 | 18.08% | 0.32% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 243,376 | $309,088 | 0.19% | 0.30% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 238,967 | $303,488 | 100.00% | 0.29% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 227,609 | $289,064 | 282.70% | 0.28% |
FMR LLC | 02/13/2025 | 225,657 | $286,585 | 11.11% | 0.27% |
PRUDENTIAL FINANCIAL INC | 02/11/2025 | 196,977 | $250,161 | 35.49% | 0.24% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 193,595 | $244,000 | 100.00% | 0.23% |
SQUAREPOINT OPS LLC | 02/14/2025 | 189,462 | $240,617 | 104.35% | 0.23% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 186,329 | $236,638 | -63.09% | 0.23% |
BARCLAYS PLC | 02/13/2025 | 181,238 | $229,000 | 1.53% | 0.22% |
D. E. SHAW & CO., INC. | 02/14/2025 | 179,515 | $227,984 | -2.82% | 0.22% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 176,703 | $224,413 | 2.75% | 0.21% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 150,000 | $190,500 | 100.00% | 0.18% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 144,060 | $182,956 | 162.95% | 0.17% |
RHUMBLINE ADVISERS | 01/30/2025 | 140,717 | $178,697 | -0.82% | 0.17% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 133,630 | $169,710 | -0.89% | 0.16% |
ARISTIDES CAPITAL LLC | 02/13/2025 | 131,900 | $167,513 | 100.00% | 0.16% |
GREEN ALPHA ADVISORS, LLC | 01/13/2025 | 111,628 | $141,768 | 157.61% | 0.14% |
XTX TOPCO LTD | 02/13/2025 | 105,056 | $133,421 | 99.89% | 0.13% |
02/14/2025 | 104,816 | $133,116 | 100.00% | 0.13% | |
INVESCO LTD. | 02/13/2025 | 100,164 | $127,209 | 9.21% | 0.12% |
CITIGROUP INC | 02/12/2025 | 99,103 | $125,861 | 50.76% | 0.12% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 98,839 | $125,526 | -15.98% | 0.12% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 93,715 | $119,018 | 2,638.60% | 0.11% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/14/2025 | 86,347 | $110,000 | 16.03% | 0.10% |
Editas Medicine, Inc. institutional Ownership - FAQ's
During the previous two years, 308 institutional investors and hedge funds held shares of Editas Medicine, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 7.31 M
VANGUARD GROUP INC: 6.82 M
MILLENNIUM MANAGEMENT LLC: 2.75 M
DIMENSIONAL FUND ADVISORS LP: 2.16 M
STATE STREET CORP: 1.87 M
GEODE CAPITAL MANAGEMENT, LLC: 1.81 M
61.85% of Editas Medicine, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 70.04 M shares in the last 24 months. This purchase volume represents approximately $100.15 M in transactions.